Suppr超能文献

在肺移植失败之前,衰老且具有炎症性的肺CD4 T细胞群体出现。

Emergence of a senescent and inflammatory pulmonary CD4 T cell population prior to lung allograft failure.

作者信息

Moshkelgosha Sajad, Levy Liran, Safavi Shahideh, Karunagaran Sumiha, Wilson Gavin, Renaud-Picard Benjamin, Madu Goodness, Ramchandani Rashi, Oliver Jillian, Watanabe Tatsuaki, Bei Ke Fan, Joe Betty, Li Qixuan, Huszti Ella, Cheung May, Hedley David, Yeung Jonathan, Keshavjee Shaf, Martinu Tereza, Juvet Stephen

机构信息

Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

出版信息

Sci Adv. 2025 Mar 21;11(12):eadp9052. doi: 10.1126/sciadv.adp9052.

Abstract

Survival after lung transplantation is limited by chronic lung allograft dysfunction (CLAD), an alloimmune fibrotic process leading to death or retransplantation after a median of 6 years. Immunosuppression fails to prevent CLAD, suggesting the existence of drug-resistant alloimmune pathways. We used time-of-flight mass cytometry to identify cells enriched in the bronchoalveolar lavage of patients with subsequent acute lung allograft dysfunction (ALAD), a risk factor for CLAD. We show that CD4CD57PD1 T cells emerge in stable patients, conferring risks for ALAD, CLAD, and death. These cells are senescent, secrete inflammatory cytokines, and fall into two oligoclonal subsets with putative cytotoxic and follicular helper functions. Last, they are associated with fibrosis in mouse and human lung allografts, where they localize near airway epithelium and B cells. Together, our findings reveal an inflammatory T cell population that predicts future lung allograft dysfunction and may represent a rational therapeutic target.

摘要

肺移植后的生存受到慢性肺移植功能障碍(CLAD)的限制,这是一种同种免疫纤维化过程,在中位时间6年后会导致死亡或再次移植。免疫抑制无法预防CLAD,这表明存在耐药性同种免疫途径。我们使用飞行时间质谱流式细胞术来识别随后发生急性肺移植功能障碍(ALAD)患者支气管肺泡灌洗中富集的细胞,ALAD是CLAD的一个危险因素。我们发现CD4CD57PD1 T细胞在病情稳定的患者中出现,会增加发生ALAD、CLAD和死亡的风险。这些细胞是衰老的,分泌炎性细胞因子,并分为两个具有假定细胞毒性和滤泡辅助功能的寡克隆亚群。最后,它们与小鼠和人类肺移植中的纤维化相关,在那里它们定位于气道上皮和B细胞附近。总之,我们的研究结果揭示了一种炎性T细胞群体,它可预测未来的肺移植功能障碍,可能是一个合理的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/183f/11927631/59f8e4e52149/sciadv.adp9052-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验